Israeli Woman Treated with COVID-19 “Passive Vaccine”

Israeli Woman Treated with COVID-19 “Passive Vaccine”

Hadassah Medical Center in partnership with the Israeli biotechnology company Kamada Ltd. in Jerusalem, Israel treated its first COVID-19 patient with what it described as a “passive vaccine.”1 Reportedly, a young female suffering from several underlying medical conditions, who had been hospitalized for several weeks and intubated, was passively vaccinated by injecting antibodies from a person who had recovered from COVID-19.2

What Is a “Passive Vaccine”?

According to The Jerusalem Post, passive vaccination is also known as immunoglobulin therapy or transfusion of convalescent plasma. For example, tetanus immune globulin is used to prevent tetanus infection (also known as lockjaw), which gives passive protection that lasts long enough until the patient’s body can produce its own antibodies against tetanus.3

Active vaccination to prevent a viral infection occurs when a person is injected with a live, attenuated or inactivated virus, which manipulates the immune system into thinking the patient has had the infectious disease and vaccine strain antibodies and artificial immunity are produced.4

First Hospital in the World to Administer Immunoglobulin G

At the beginning of the COVID-19 pandemic, Hadassah Medical Center began collecting plasma rich with antibodies from coronavirus patients who had recovered from the infection with the goal of producing a treatment for severely ill COVID-19 patients.5 The plasma collected from the recovered patients was processed by Kamada, Ltd. to produce an IgG-based antibody treatment for coronavirus patients in severe conditions.6

The first dose of the “passive vaccine” was provided to a young woman with a pre-existing medical condition whose computerized tomography (CT) scan showed white lungs, an indication that she was critically ill with the infection. All of the known treatments for coronavirus, including the use of an extracorporeal membrane oxygenation (ECMO) machine, had not improved her condition.7

Several hours after she received the immunoglobulin, it was observed that the patient’s condition stabilized, leading physicians to become cautiously optimistic.8

Kamada Announces Compassionate Use for Its IgG Therapy for COVID-19

In June 2020, Kamada completed manufacturing its first batch of a plasma-derived IgG product for COVID-19 utilizing the company’s proprietary IgG platform technology. Additional production is ongoing and the first vials are now available for compassionate use in Israel.9 Compassionate drug use is the use of a new, unapproved drug to treat a seriously ill patient when no other treatments are available.10

Kamada To Expand Its IgG Therapy to the United States

In order to expand its clinical development program to the U.S., Kamada, with the support of Kedrion Biopharma based in New Jersey, intends to conduct a pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) in order to obtain FDA’s approval of the proposed clinical development program.11

Kedrion is currently collecting COVID-19 convalescent plasma from U.S. recovered patients that will be used by Kamada to manufacture additional vials of the product. Kedrion is collecting the plasma through its plasma business unit, KEDPLASMA, at 23 FDA approved centers across the U.S.12


1 Jaffe-Hoffman M. Hadassah treats COVID-19 patient with new concentrated passive vaccine. The Jerusalem Post June 24, 2020.
2 Ibid.
3 Mayo Clinic. Tetanus Immune Globulin. Feb. 1, 2020.
4 Ibid.
5 Stern A. Hadassah Hospital First in World to Test Passive Coronavirus Vaccine. Hamodia June 24, 2020.
6 Ibid.
7 Ibid.
8 Ibid.
9 Globe Newswire. Kamada Announces Availability of its Plasma-Derived Hyperimmune IgG Therapy for Coronavirus Disease (COVID-19) for Compassionate Use Treatment in Israel. BioSpace June 17, 2020.
10 U.S. Food and Drug Administration. Expanded Access. Apr. 27, 2020.
11 See Footnote 8.
12 Ibid.

10 Responses to "Israeli Woman Treated with COVID-19 “Passive Vaccine”"

  1. Joy Metcalf   July 6, 2020 at 3:43 pm

    This makes more sense than some of the other vaccines they’re coming up with. And wasn’t it an immunoglobulin shot that women used to have if they were exposed to Rubella and might be pregnant?

  2. Frances Lilian Wellington   July 6, 2020 at 4:20 pm

    Excellent. Thank you Hadassah Medical Center, Kamada Ltd. Thank you to the patient for trying all options and The Jerusalem Post for gathering this information. This progress is welcomed. In addition to the use here for the recovery of critical care patients I hope this treatment offers a risk free option as an alternative to vaccine for those of us who prefer not to have a vaccine, as well. I hope this treatment obtains FDA approval.

  3. Pat   July 6, 2020 at 5:20 pm

    This is actually nothing new. Prior to the availability of the Salk vaccine against polio, a family friend we had just visited developed polio a few days later. My sister and I both received gamma globulin shots. We did not develop polio.

  4. John   July 6, 2020 at 7:40 pm

    Anything at all to do with vaccines involves nefarious agendas and individuals such as the Gates foundation. Wake up people!

  5. Lynnette   July 6, 2020 at 8:05 pm

    Are there other ingredients in this?

  6. Julie   July 7, 2020 at 7:56 am

    I am fortunate to know of a food supplement that increases IgG in our bodies & therefore improving our immune system greatly. That, with Glycans, are the answer to protect cells & modulate our immune system.
    The passive vaccine certainly sounds better than every other one they are testing with so many
    toxic side effects causing more problems for us. I wouldn’t have any of them.Why are they trying to make vaccines mandatory -who does Gates think he is? In cahoots with Big Pharma. Heaven help us if they do make vaccinations mandatory which is already happening with the Flu vaccine if you want to visit loved ones in nursing homes, or send your child to school. We need to stand u for our own rights & not be told what to do.It’s our life.

  7. nathalie   July 7, 2020 at 9:06 am

    what is really not clear is how those immunoglobulins are manufactured after collection of the original plasma. What does the process involve? what is in those injections beside the IgG?

  8. Brian James   July 9, 2020 at 6:04 pm

    This speaks for itself!

    JULY 07, 2020 New Docs: NIH Owns Half of Moderna Vaccine

    New documents obtained by Axios and Public Citizen suggest that the National Institute of Health (NIH) owns half the key patent for Moderna’s controversial COVID vaccine and could collect half the royalties. In addition, four NIH scientists have filed their own provisional patent application as co-inventors.

  9. Redpill   July 12, 2020 at 10:24 pm

    You cannot develop immunity to tetanus. It’s a spore and not a transmittable disease. Tetanus spores are everywhere around us. Wounds that bleed will never result in tetanus because the tetanus bacillus is anaerobic.

    “How can the Tetanus vaccine induce immunity, when contracting the disease naturally does not give immunity?”–NVIC

    So if the model they are using is tetanus, it ain’t gonna work.


Leave a Reply

Your email address will not be published.